When was Alpha Genesis founded?

Alpha Genesis was founded in 2003 and raised its 1st funding round 15 years after it was founded.

Where is Alpha Genesis located?

Alpha Genesis is headquartered in Yemassee, United States.

How many employees does Alpha Genesis have?

As of Jun 30, 2026, the latest employee count at Alpha Genesis is 106.

Is Alpha Genesis a funded company?

Alpha Genesis is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Jan 13, 2018.

When was the latest funding round of Alpha Genesis?

Alpha Genesis' latest funding was a $***** Series B round on Jan 13, 2018, with participation from 0 investor.

Where does Alpha Genesis rank among its competitors?

Alpha Genesis ranks 6th amongst 116 active competitors, of which 11 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Magnitude Biosciences, which secured an undisclosed amount in May, 2025.

Who are the top competitors of Alpha Genesis?

Alpha Genesis' top competitors include TransCure bioServices, GenOway and Vivo Bio Tech. Among them, Magnitude Biosciences secured the most recent funding round in May, 2025.

Alpha Genesis - 2026 Company Profile, Funding & Competitors

Alpha Genesis is a series B company based in Yemassee (United States), founded in 2003. It operates as a Preclinical research services specializing in nonhuman primate models for therapy development. Alpha Genesis has raised $12.5M in funding. The company has 116 active competitors, including 11 funded and 21 that have exited. Its top competitors include companies like TransCure bioServices, GenOway and Vivo Bio Tech.

Company Details

Preclinical research services specializing in nonhuman primate models for therapy development. They deliver comprehensive preclinical research services to advance biomedical discovery. They provide dependable resources tailored to sponsor needs, including primate models, quarantine services, colony management, breeding, and biological materials. Their GLP-capable laboratory and surgical platforms support complex pharmacology, toxicology, and translational studies. They offer services spanning exploratory research through IND-enabling studies, designed to de-risk candidate therapies and provide reproducible outcomes. They integrate advanced imaging, molecular analytics, and specialized model development to help sponsors generate data for clinical advancement. They uphold high standards of animal welfare, biosecurity, and regulatory compliance.

Website: www.alphagenesisinc.com/
Social
Email ID: *****@alphagenesisinc.com
Phone Number: +1 **********

Key Metrics

Founded Year

2003

Location

Yemassee, United States

Stage

Series B

Total Funding

$12.5M in 1 round

Latest Funding Round

Series B, Jan 13, 2018, $*****

Ranked

6^th among 116 active competitors

Employee Count

106 as on Jun 30, 2026

Similar Companies

TransCure bioServices & 131 more

View Alpha Genesis' full profile

Alpha Genesis is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Alpha Genesis Inc CIN: 3453767 , United States, Active		-	104 (As on Dec 31, 2016)	-
ALPHA GENESIS, INC. CIN: 541800459 , United States, Active		-	210 (As on Dec 31, 2024)	-

Alpha Genesis has raised a total funding of $12.5M over 1 round.

Here is the list of recent funding rounds of Alpha Genesis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 13, 2018	4924140	Series B	5515313	8754937	8076392	5681225

Access funding benchmarks and valuations. Sign up today!

View details of Alpha Genesis's funding rounds and investors

Alpha Genesis' employee count trend

Alpha Genesis has 106 employees as of Jun 26. Here is Alpha Genesis's employee count trend over the years:

Uncover Alpha Genesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alpha Genesis include TransCure bioServices, GenOway and Vivo Bio Tech. Here is the list of Top 10 competitors of Alpha Genesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TransCure bioServices 2012, Archamps (France), Series B	Developer of humanized animal models for preclinical studies	$3.58M	Financiere Arbevel, Savoie Mont Blanc Angels ... & 5 others	59/100
2nd	GenOway 1999, Lyon (France), Public	Provider of transgenic rodent models and customized cell lines for preclinical development	$11.6M	Eurostars, Siparex & 7 others	58/100
3rd	Vivo Bio Tech 2004, Hyderabad (India), Public	CRO providing drug development, discovery and biologic research services	-	BIRAC	52/100
4th	InVivo Biosystems 2019, Eugene (United States), Series A	Provider of animal models for in-vivo analytical services	$8.16M	Rogue Venture Partners, Launch Oregon & 6 others	46/100
5th	Magnitude Biosciences 2018, Durham (United Kingdom), Seed	Provider of early in vivo whole-organism high-throughput phenotypic screening and follow-up assays for drug discovery	$2.6M	Northstar Ventures, Saker Capital & 10 others	46/100
6th	Alpha Genesis 2003, Yemassee (United States), Series B	Preclinical research services specializing in nonhuman primate models for therapy development	$12.5M	-	45/100
7th	Explora BioLabs 2004, San Diego (United States), Acquired	Provider of discovery pharmacology and vivarium services for biotechnology and pharmaceutical clients	-	Milk Street Ventures, Aspect Investors & 2 others	42/100
8th	Neurofit 1996, Illkirch Graffenstaden (France), Acquired	Animal models of neurological and psychiatric disorders for drug discovery	-	-	39/100
9th	Fibrofind United Kingdom, Acquired	Provider of preclinical drug development research solutions for fibrotic diseases	-	-	39/100
10th	Noble Life Sciences 2010, Woodbine (United States), Seed	Preclinical contract research organization offering standard GLP and non-GLP services	$335K	1776, TEDCO & 3 others	37/100